Volume | 514,886 |
|
|||||
News | - | ||||||
Day High | 71.855 | Low High |
|||||
Day Low | 70.01 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
CONMED Corporation | CNMD | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
70.65 | 70.01 | 71.855 | 71.76 | 70.12 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
9,840 | 514,886 | US$ 70.93 | US$ 36,519,624 | - | 61.05 - 138.47 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:00:00 | 60,336 | US$ 71.76 | USD |
CONMED (CNMD) Options Flow Summary
CONMED Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
3.12B | 30.78M | - | 1.24B | 64.46M | 2.09 | 48.43 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
CONMED News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CNMD Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 62.28 | 71.855 | 62.00 | 67.62 | 749,121 | 9.48 | 15.22% |
1 Month | 77.51 | 80.65 | 61.05 | 69.93 | 687,936 | -5.75 | -7.42% |
3 Months | 84.21 | 88.595 | 61.05 | 75.85 | 546,556 | -12.45 | -14.78% |
6 Months | 102.82 | 117.27 | 61.05 | 87.74 | 512,711 | -31.06 | -30.21% |
1 Year | 125.07 | 138.47 | 61.05 | 99.29 | 438,900 | -53.31 | -42.62% |
3 Years | 141.69 | 159.11 | 61.05 | 106.62 | 365,909 | -69.93 | -49.35% |
5 Years | 100.14 | 159.11 | 37.66 | 101.43 | 357,608 | -28.38 | -28.34% |
CONMED Description
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgery. The firm currently reports through two reporting units, orthopedic surgery (52% of 2018 sales) and general surgery (48%). From a geographic perspective the firm is U.S. centric, with domestic sales accounting for 52% of revenue, EMEA accounting for 19%, APAC at 17%, and the non-U.S. Americas region driving the remaining 12%. |